Walleye Capital
IMGN

Walleye Capital’s Immunogen Inc IMGN Stock Holding History

Walleye Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-111,863
Closed -$3.32M – 6129
2023
Q4 		$3.32M Buy
+111,863
New +$2.23M 0.01% 1391
2023
Q3 		– Sell
-108,000
Closed -$2.04M – 5471
2023
Q2 		$2.04M Buy
+108,000
New +$1.28M 0.01% 1308
2022
Q3 		– Sell
-215,198
Closed -$968K – 3639
2022
Q2 		$968K Buy
215,198
+158,682
+281% +$689K 0.03% 654
2022
Q1 		$269K Buy
56,516
+28,656
+103% +$159K 0.01% 1367
2021
Q4 		$207K Buy
+27,860
New +$173K 0.01% 1453
2021
Q1 		– Sell
-11,954
Closed -$77 – 1399
2020
Q4 		$77 Buy
+11,954
New +$69.7K 0.01% 837
2020
Q1 		– Sell
-65,262
Closed -$333K – 1846
2019
Q4 		$333K Sell
65,262
-31,378
-32% -$106K 0.02% 873
2019
Q3 		$234K Buy
96,640
+56,640
+142% +$150K 0.01% 1127
2019
Q2 		$87K Buy
+40,000
New +$94.6K 0.01% 1259

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's IMGN Position: Q1 2024 in Review

Walleye Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 111,863 shares — an estimated $3.32M sold.

Walleye Capital first reported a position in IMGN in Q2 2019 and held it in 9 quarters. The position peaked at $3.32M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Walleye Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 111,863 Immunogen Inc shares in Q1 2024, an estimated $3.32M.
  • Walleye Capital first reported a position in Immunogen Inc in Q2 2019 and held it in 9 quarters.
  • Walleye Capital's Immunogen Inc position peaked at $3.32M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.